Partnership Opportunities

For the past three years, companies have partnered with the Annual Gene Therapy for Ophthalmic Disorders Summit to elevate their brand, forge new connections, and demonstrate their expertise as a company that can provide invaluable assistance in the efforts to get ophthalmic drugs to those who need them.

Partnering with us will bring you closer to 130+ preclinical, translational, clinical, regulatory, and immunology colleagues leaders in the field, actively seeking networking and collaborating opportunities to overcome the challenges they face.

Your brand, your message, and your reputation – showcased in front of the leading experts in the gene therapy field.

For more information and to explore a bespoke partnership package which meets your business goals, email sponsor@hansonwade.com

Experts Need Your Help With:

HW230524-4th-Gene-Therapy-for-Ophthalmic-Disorders-logo-2048x433

Contract Research Organizations with appropriate, ocular-specific models and/or experience running effective clinical trials

HW230524-4th-Gene-Therapy-for-Ophthalmic-Disorders-logo-2048x433

Highly specific ophthalmic equipment that facilitate the targeted and precise delivery of gene therapies to ocular tissue

HW230524-4th-Gene-Therapy-for-Ophthalmic-Disorders-logo-2048x433

Advanced imaging technology and expertise to support the visualization, monitoring, and assessment of ocular tissues and gene therapy interventions

Previous Attendees:

Gene Therapy for Ophthalmic Disorders Companies Attending

Audience Breakdown:

Capture